Quest Laboratories (NSE:QUESTLAB) Accounts Payable & Accrued Expense: ₹46 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹95.00
! 5 Warning Signs
View Full Analysis

What is Quest Laboratories Accounts Payable & Accrued Expense?

Quest Laboratories NSE:QUESTLAB +5.56% 44 Accounts Payable & Accrued Expense is ₹46 Mil as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 5 warning signs investors should review.

Quest Laboratories's quarterly accounts payable & accrued expense increased from Mar. 2025 (₹80 Mil) to Sep. 2025 (₹97 Mil) but then declined from Sep. 2025 (₹97 Mil) to Mar. 2026 (₹46 Mil).

Quest Laboratories's annual accounts payable & accrued expense declined from Mar. 2024 (₹247 Mil) to Mar. 2025 (₹80 Mil) and declined from Mar. 2025 (₹80 Mil) to Mar. 2026 (₹46 Mil).

Quest Laboratories Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Accounts Payable & Accrued Expense Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 183.93 268.60 247.38 79.88 45.72

Quest Laboratories Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only 247.38 0.00 79.88 97.50 45.72
NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
Accounts Payable & Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of ₹46 Mil mean?
Quest Laboratories (NSE:QUESTLAB) has a Accounts Payable & Accrued Expense of ₹46 Mil as of Mar. 2026. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Quest Laboratories and its competitors.
Is Quest Laboratories' Accounts Payable & Accrued Expense too high?
Quest Laboratories' current Accounts Payable & Accrued Expense is ₹46 Mil. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Accounts Payable & Accrued Expense compare to LLY and JNJ?
Quest Laboratories' Accounts Payable & Accrued Expense of ₹46 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Drug Manufacturers company?
A good Accounts Payable & Accrued Expense depends on the Drug Manufacturers industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current Accounts Payable & Accrued Expense is ₹46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Accounts Payable & Accrued Expense of ₹46 Mil. The current Accounts Payable & Accrued Expense is ₹46 Mil. Quest Laboratories' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Accounts Payable & Accrued Expense is ₹46 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

Accounts Payable & Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹95.00
Price